自從20世紀50年代流式細胞術被應用以來，科學家們能夠在單細胞水平上快速且同時檢測多個參數，這也使流式細胞術成為了生物醫學研究和臨床應用中有力的分析技術之一。那么對于從細胞表面CD marker到細胞內修飾靶標（如磷酸化蛋白）的成功檢測而言，除了使用經嚴格驗證優化的抗體，合理優化的固定、通透步驟也起著關鍵的作用。作為指導方針，本次講座將與您分享CST流式細胞術專家在日常的試驗工作中經常使用的經驗和技巧。
?
點擊上方圖片，報名后可觀看錄播視頻
嘉賓簡介：
Dr. Yu Gang Tu(William) is an Asia Pacific Application and Australian Key AccountManager for Cell Signaling Technology, based in MelbourneAustralia. Enrolled through Monash University Australia, he received hisPhD degree by investigating the roles of CDA1 (cell division of autoantigen1)in cell-cycle/growth and diabetic renal fibrosis development, from cells tomouse models. During his post-doctoral projects, Dr. Tu also discoveredand focused on how HDL affects the levels of some small/microRNAs that may playimportant role in inflammatory-associated diseases, together with developingnew test-platforms for assessing HDL capacity of anti-inflammation to predictits underlying risk for atherosclerosis. Dr.Tu has many industrial experiencesby working through Genelabs Diagnostics as R&D scientist fordiagnostic kit development, and Bayer Healthcare as Asia-Pacific ApplicationManager in charge of automated diagnostic immunoassays.
網絡研討會報名鏈接：
http://xy.bioon.com/live/webinar_play_new/395.html
報名后即可回看本研討會的錄播視頻。
?
?
?
CST在生物谷行云學院建立了企業學堂，學堂里上載了一系列課程，包括以下視頻：
7．創新的蛋白翻譯后修飾篩選平臺PTMScan?**技術簡介；
12．Akt/MAPK相關信號通路研究進展和關鍵蛋白研究策略;
14．PD-L1,Tumor Immunology Checkpoint and Beyond；
15．ChIP & ChIP-Seq實驗原理與成功要素及NGS測序數據分析解讀；
19. IHC 和 mIHC 在疾病研究診斷中的方法介紹及注意事項；
21. 具有巨大潛力的天然免疫和腫瘤免疫干預靶標——cGAS-STING信號通路。
23. 掌控Phospho-Flow: 巧用細胞內、外流式細胞術優化免疫細胞活化分析
?
?
歡迎感興趣的老師和同學前往觀看。